Nevro (NVRO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NVRO Annual Cash Flow →
A period-by-period view of cash flow from Nevro to Dec 31 2023 helps clarify how Dec 31 2024's cash position has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
12 Months
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-113.44
Depreciation & amortization7.95
Amortization of Other Assets6.93
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges31.53
Provision For Loan Losses Expensed1.32
Inventories Decrease /-Increase15.86
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.53
Share-based Compensation51.19
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-27.89
Noncash Gain Loss On Extinguishment Of Debt-
Payments Of Original Issue Discount-
Payment For Contingent Consideration Liability Operating Activities2.63
Unrealized Gain Loss On Foreign Currency Transaction Net-
Increase Decrease In Accrued Liabilities And Other Current Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable5.85
Increase (Decrease) in Accounts Payable2.26
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.69
Other Working Capital-0.97
Other Noncash Income (Expense)10.52
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.80
Discontinued operations0.00
Net Cash flow from Operating Activities-19.44
Investing Activities
Capital Expenditures-9.79
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities184.14
Payments to Acquire Available-for-sale Securities, Debt-159.68
Real Estate Investments0.00
Investment In Private Company-
Repayment From Investment In Private Company-
Payment For Investment In Private Company-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-0.05
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities14.63
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.33
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.55
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-112.25
Payment Of Deferred Offering Costs-
Payments Of Convertible Notes Initial Issuance Discount And Debt Issuance Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations104.82
Payments Of Convertible Notes Debt Issuance Costs-
Proceeds From Term Debt And Warrants-
Proceeds From Issuance Of Long Term Debt And Warrants Exercises-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-4.21
Effect of exchange rate on cash flow-0.76
Discontinued operations0.00
Free Cash Flow-29.23
Total Cash Flow-9.77
4 historic quarters locked

Sign in to unlock the full Nevro cash flow history.

About Nevro Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 12, 2024
  • Source: nvro-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-24-124689

Figures are derived from filed reports and may be restated. Historical data is subject to revision.